A week after extremely promising news about two US vaccines, developers of Russia’s Sputnik V COVID-19 vaccine said it has shown an efficacy rate better than 91%.
A week after extremely promising news about two US vaccines, developers of Russia’s Sputnik V COVID-19 vaccine said it has shown an efficacy rate better than 91%.